Sierra Ocean’s Neurocrine Biosciences NBIX Stock Holding History

Sierra Ocean’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15	Closed	-$1.89K	–	620
2025 Q2	$1.89K	Sell	15 -32	-68%	-$3.67K	﹤0.01%	777
2025 Q1	$5.2K	Buy	+47	New	+$5.95K	﹤0.01%	580

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sierra Ocean's NBIX Position: Q3 2025 in Review

Sierra Ocean sold out of Neurocrine Biosciences (NBIX) in Q3 2025, closing a stake of 15 shares — an estimated $1.89K sold.

Sierra Ocean first reported a position in NBIX in Q1 2025 and held it in 2 quarters. The position peaked at $5.2K in Q1 2025. 649 funds tracked by Wall St. Rank hold NBIX as of Q3 2025.

Sierra Ocean reported no remaining Neurocrine Biosciences position as of Q3 2025 after selling out during the quarter.
Sierra Ocean sold 15 Neurocrine Biosciences shares in Q3 2025, an estimated $1.89K.
Sierra Ocean first reported a position in Neurocrine Biosciences in Q1 2025 and held it in 2 quarters.
Sierra Ocean's Neurocrine Biosciences position peaked at $5.2K in Q1 2025.
649 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2025.

Based on Sierra Ocean's 13F filing for Q3 2025, filed 7 Nov 2025.